Nifedipine suppositories - RDD Pharma

Drug Profile

Nifedipine suppositories - RDD Pharma

Alternative Names: Coated Nifedipine Suppositories - RDD Pharma; Nifedipine coated suppositories - RDD Pharma; RDD-1219

Latest Information Update: 08 Jan 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator RDD Pharma
  • Class Antihypertensives; Dihydropyridines; Heart failure therapies; Ischaemic heart disorder therapies; Small molecules
  • Mechanism of Action Calcium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase III Fissure in ano

Most Recent Events

  • 04 Jan 2018 Phase-III clinical trials in Fissure in ano (Adjunctive treatment) in Bulgaria, Romania, Poland, Moldova (Rectal) (NCT02527109)
  • 04 Jan 2018 RDD Pharma announces intention to submit MAA to the EMA for Fissure in ano in 2019
  • 04 Jan 2018 RDD Pharma completes enrolment in its phase III trial for Fissure in ano in Bulgaria, Romania, Moldova and Poland (NCT02527109)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top